Summary Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis Essential resource for top-line data and analysis covering the Singapore pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Key highlights - The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. - The Singaporean pharmaceuticals market had total revenues of $0.9bn in 2017, representing a compound annual growth rate (CAGR) of 4.6% between 2013 and 2017. - Growth is bolstered by an ageing population; meaning there will be a higher demand for drugs for conditions linked to ageing such as arthritis, dementia and respiratory diseases. - Growth in the Singaporean pharmaceuticals market has helped the city-state become a regional hub for the manufacturing, research and development for multinational pharmaceutical companies
Scope - Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore - Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore - Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance - Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts
Reasons to buy - What was the size of the Singapore pharmaceuticals market by value in 2017? - What will be the size of the Singapore pharmaceuticals market in 2022? - What factors are affecting the strength of competition in the Singapore pharmaceuticals market? - How has the market performed over the last five years? - Who are the top competitiors in Singapore’s pharmaceuticals market?
Our reports have been used by over 10K customers, including:
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018, provides an overview of the Human Papillomavirus (HPV) Associated...
Thalassemia - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H2 2018, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape. Thalassemia is a group of inherited...